These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 30854133)

  • 21. Overexpression of miR-15b Promotes Resistance to Sunitinib in Renal Cell Carcinoma.
    Lu L; Li Y; Wen H; Feng C
    J Cancer; 2019; 10(15):3389-3396. PubMed ID: 31293642
    [No Abstract]   [Full Text] [Related]  

  • 22. The Immune-Related Gene HCST as a Novel Biomarker for the Diagnosis and Prognosis of Clear Cell Renal Cell Carcinoma.
    Zhou Y; Wang X; Zhang W; Liu H; Liu D; Chen P; Xu D; Liu J; Li Y; Zeng G; Li M; Wu Z; Zhang Y; Wang X; DiSanto ME; Zhang X
    Front Oncol; 2021; 11():630706. PubMed ID: 33968730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apolipoprotein C1 (APOC1): A Novel Diagnostic and Prognostic Biomarker for Clear Cell Renal Cell Carcinoma.
    Cui Y; Miao C; Hou C; Wang Z; Liu B
    Front Oncol; 2020; 10():1436. PubMed ID: 32974161
    [No Abstract]   [Full Text] [Related]  

  • 24. Low level of isocitrate dehydrogenase 1 predicts unfavorable postoperative outcomes in patients with clear cell renal cell carcinoma.
    Laba P; Wang J; Zhang J
    BMC Cancer; 2018 Aug; 18(1):852. PubMed ID: 30153799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The level of zinc finger of the cerebellum 2 is predictive of overall survival in clear cell renal cell carcinoma.
    Shang Z; Zhao T; Ou T; Yan H; Cui B; Wang Q; Wu J; Jia C; Cui X; Li J
    Transl Androl Urol; 2020 Apr; 9(2):614-620. PubMed ID: 32420167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of the Prognostic Values of the CXCR1-7 in Clear Cell Renal Cell Carcinoma (ccRCC) Microenvironment.
    Wu Z; Zhang Y; Chen X; Tan W; He L; Peng L
    Front Mol Biosci; 2020; 7():601206. PubMed ID: 33324682
    [No Abstract]   [Full Text] [Related]  

  • 27. The Landscape of Iron Metabolism-Related and Methylated Genes in the Prognosis Prediction of Clear Cell Renal Cell Carcinoma.
    Mou Y; Zhang Y; Wu J; Hu B; Zhang C; Duan C; Li B
    Front Oncol; 2020; 10():788. PubMed ID: 32528886
    [No Abstract]   [Full Text] [Related]  

  • 28. Elevated CD36 expression correlates with increased visceral adipose tissue and predicts poor prognosis in ccRCC patients.
    Xu WH; Qu YY; Wang J; Wang HK; Wan FN; Zhao JY; Zhang HL; Ye DW
    J Cancer; 2019; 10(19):4522-4531. PubMed ID: 31528216
    [No Abstract]   [Full Text] [Related]  

  • 29. Does chromophobe renal cell carcinoma have better survival than clear cell renal cell carcinoma? A clinical-based cohort study and meta-analysis.
    Jiang HM; Wei JH; Zhang ZL; Fang Y; Zhou BF; Chen ZH; Lu J; Liao B; Zhou FJ; Luo JH; Chen W
    Int Urol Nephrol; 2016 Feb; 48(2):191-9. PubMed ID: 26589610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of immunohistochemical staining for myoferlin in clear cell renal cell carcinoma and its association with epidermal growth factor receptor expression.
    Jung M; Lee C; Park JH; Moon KC
    Urol Oncol; 2019 Nov; 37(11):812.e9-812.e16. PubMed ID: 31421995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Up-regulation of SR-BI promotes progression and serves as a prognostic biomarker in clear cell renal cell carcinoma.
    Xu GH; Lou N; Shi HC; Xu YC; Ruan HL; Xiao W; Liu L; Li X; Xiao HB; Qiu B; Bao L; Yuan CF; Zhou YL; Hu WJ; Chen K; Yang HM; Zhang XP
    BMC Cancer; 2018 Jan; 18(1):88. PubMed ID: 29357836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The SLC Family Are Candidate Diagnostic and Prognostic Biomarkers in Clear Cell Renal Cell Carcinoma.
    Kang W; Zhang M; Wang Q; Gu D; Huang Z; Wang H; Xiang Y; Xia Q; Cui Z; Jin X
    Biomed Res Int; 2020; 2020():1932948. PubMed ID: 32461965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic and prognostic tissuemarkers in clear cell and papillary renal cell carcinoma.
    Kroeze SG; Bijenhof AM; Bosch JL; Jans JJ
    Cancer Biomark; 2010; 7(6):261-8. PubMed ID: 21694464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TPX2 as a prognostic indicator and potential therapeutic target in clear cell renal cell carcinoma.
    Glaser ZA; Love HD; Guo S; Gellert L; Chang SS; Herrell SD; Barocas DA; Penson DF; Cookson MS; Clark PE
    Urol Oncol; 2017 May; 35(5):286-293. PubMed ID: 28108243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low Expression Levels of SLC22A12 Indicates a Poor Prognosis and Progresses Clear Cell Renal Cell Carcinoma.
    Xu J; Liu Y; Liu J; Shou Y; Xiong Z; Xiong H; Xu T; Wang Q; Liu D; Liang H; Yang H; Yang X; Zhang X
    Front Oncol; 2021; 11():659208. PubMed ID: 34249694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High expression of FER tyrosine kinase predicts poor prognosis in clear cell renal cell carcinoma.
    Wei C; Wu S; Li X; Wang Y; Ren R; Lai Y; Ye J
    Oncol Lett; 2013 Feb; 5(2):473-478. PubMed ID: 23420638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PTPRO predicts patient prognosis and correlates with immune infiltrates in human clear cell renal cell carcinoma.
    Gan J; Zhang H
    Transl Cancer Res; 2020 Aug; 9(8):4800-4810. PubMed ID: 35117843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IGFLR1 as a Novel Prognostic Biomarker in Clear Cell Renal Cell Cancer Correlating With Immune Infiltrates.
    Song W; Shao Y; He X; Gong P; Yang Y; Huang S; Zeng Y; Wei L; Zhang J
    Front Mol Biosci; 2020; 7():565173. PubMed ID: 33324675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High Expression of Stearoyl-CoA Desaturase 1 Predicts Poor Prognosis in Patients with Clear-Cell Renal Cell Carcinoma.
    Wang J; Xu Y; Zhu L; Zou Y; Kong W; Dong B; Huang J; Chen Y; Xue W; Huang Y; Zhang J
    PLoS One; 2016; 11(11):e0166231. PubMed ID: 27861513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systematic analyses of the role of prognostic and immunological EIF3A, a reader protein, in clear cell renal cell carcinoma.
    Zhang Y; Hua X; Shi H; Zhang L; Xiao H; Liang C
    Cancer Cell Int; 2021 Dec; 21(1):680. PubMed ID: 34923969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.